Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS2 Cream for Ichthyosis in Sjögren-Larsson Syndrome
NCT02402309Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Mar 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in Sjögren-Larsson syndrome (SLS), sponsored by Aldeyra Therapeutics. Started Mar 2015; status: completed.
02
Drugs
reproxalap
03
Conditions
Sjögren-Larsson syndrome (SLS)
Beyond the preview
Go deeper on NCT02402309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402309.